Investing.com -- Cardiff Oncology Inc (NASDAQ: CRDF) reported second-quarter earnings that missed analyst expectations, sending shares tumbling 22% as investors reacted to the wider-than-expected loss ...

The footwear manufacturer posted adjusted earnings of $0.55 per diluted share for the quarter ended June 30, 2025, more than double the analyst estimate of $0.25. Revenue climbed 7.5% YoY to $105.6 ...

Ryerson Holding Corporation (NYSE: RYI), a metals processor and distributor, reported second-quarter earnings that fell short of analyst expectations as the compa ...

BlueLinx’s performance was hampered by challenging market conditions despite volume increases in both specialty and structural products. Gross profit declined 2% YoY to $120 million, with gross margin ...

Investing.com -- Aclaris Therapeutics Inc (NASDAQ: ACRS) stock surged 20% in after-hours trading following the announcement of positive top-line results from its Phase 2a trial of ATI-2138 in patients ...